Ambuja Cements stock reports profit pressure at a 52-week low

Published on 09/29/2026 at 13:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Motilal Oswal retained a Buy rating and an INR 500.00 target on July 28, 2026. Fiscal 2025-26 revenue reached INR 40,656 crore.

Ambuja Cements, INE079A01024, Illustration mit AI erstellt.

Ambuja Cements (ISIN INE079A01024) stood at INR 365.75 on the NSE at 3:57 p.m. IST on September 29, 2026, matching its 52-week low. The stock's market backdrop contrasts with fiscal 2025-26 revenue of INR 40,656 crore and profit after tax of INR 5,637 crore, according to Ambuja Cements.

Fiscal 2025-26 delivered growth

Ambuja Cements' revenue from operations increased from INR 35,336 crore in fiscal 2024-25 to INR 40,656 crore in fiscal 2025-26. Profit after tax also rose from INR 5,294 crore to INR 5,637 crore over the same periods, while cement sales volume advanced from 63 million tonnes to 74 million tonnes, the company's investor-relations data shows.

The annual figures provide a constructive operating base, but the share-price signal remains weaker. The NSE quote matched the 52-week low of INR 365.75, compared with a 52-week high of INR 588.75 on September 29, 2026.

Motilal Oswal keeps INR 500 target

DSIJ reported on July 28, 2026, that Motilal Oswal Financial Services retained its Buy recommendation and an INR 500.00 target. The report cited cost optimization, capacity utilization, acquired-asset integration and expansion execution as key variables.

Motilal Oswal's report covered first-quarter fiscal 2027 revenue of INR 9,500 crore, EBITDA of INR 1,590 crore and adjusted profit after tax before minority interest of INR 580 crore. Revenue fell 8 percent year over year, EBITDA declined 19 percent and adjusted profit after tax dropped 40 percent, while the broker said EBITDA exceeded its estimate by 4 percent.

Stock valuation meets operating pressure

Ambuja Cements had a market capitalization of INR 931.6 billion on September 29, 2026. The combination of higher full-year revenue and profit with weaker first-quarter comparisons leaves cost savings and volume recovery as the clearest operating tests for the next reported period.